0001127602-19-011378.txt : 20190314
0001127602-19-011378.hdr.sgml : 20190314
20190314170735
ACCESSION NUMBER: 0001127602-19-011378
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190312
FILED AS OF DATE: 20190314
DATE AS OF CHANGE: 20190314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abdel-Malek Aiman
CENTRAL INDEX KEY: 0001670040
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33462
FILM NUMBER: 19681848
MAIL ADDRESS:
STREET 1: C/O INSULET CORPORATION
STREET 2: 600 TECHNOLOGY PARK DRIVE, SUITE 200
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSULET CORP
CENTRAL INDEX KEY: 0001145197
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043523891
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
BUSINESS PHONE: 978-600-7000
MAIL ADDRESS:
STREET 1: 100 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-03-12
0001145197
INSULET CORP
PODD
0001670040
Abdel-Malek Aiman
C/O INSULET CORPORATION
100 NAGOG PARK
ACTON
MA
01720
1
EVP & Chief Technology Officer
Common Stock
2019-03-12
4
M
0
19915
31.20
A
43907
D
Common Stock
2019-03-12
4
M
0
5686
46.22
A
49593
D
Common Stock
2019-03-12
4
M
0
1748
74.50
A
51341
D
Common Stock
2019-03-12
4
S
0
27349
94.0295
D
23992
D
Employee Stock Option (Right to Buy)
31.20
2019-03-12
4
M
0
19915
0
D
2026-03-28
Common Stock
19915
11967
D
Employee Stock Option (Right to Buy)
46.22
2019-03-12
4
M
0
5686
0
D
2027-02-22
Common Stock
5686
5686
D
Employee Stock Option (Right to Buy)
74.50
2019-03-12
4
M
0
1748
0
D
2028-02-14
Common Stock
1748
5247
D
Includes 4,674 restricted stock units granted on March 28, 2016, which vest on March 28, 2019; 4,006 performance share units granted on March 28, 2016, which vest on March 28, 2019; 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $93.67 to $94.53. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
/s/ David Colleran, attorney-in-fact
2019-03-14